Genetic variation in ADIPOQ, rs1501299 (G267T), decreases serum adiponectin levels in patients with breast cancer, and an association between ADIPOQ genetic variation and breast cancer risk has been found in patients with postmenopausal breast cancer in Egypt [40]. Here, ADIPOQ is linked to breast carcinoma.